FIELD: pharmaceutical industry.
SUBSTANCE: invention refers to pharmaceutical industry, namely to anti-metastatic agent. Use of a liquid extract of mountain ash (Sorbus aucuparia L.), obtained by extracting the leaves of mountain ash, crushed to a particle size of 0.3–0.5 cm in diameter, 40 % ethyl alcohol at a temperature of 75 °C for 60 minutes, as an anti-metastatic and anti-metastatic action of cyclophosphamide.
EFFECT: above-described agent expands the arsenal of herbal products that have a more pronounced inhibitory effect on the development of metastases and increase the anti-metastatic effect of cytostatics.
1 cl, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT WITH ANTITUMOR AND ANTIMETASTATIC ACTIVITY, INCREASING ANTIMETASTATIC EFFECT OF CYCLOPHOSPHAN | 2015 |
|
RU2578457C1 |
| MEANS FOR ANTIMETASTATIC ACTIVITY AND IMPROVED ANTIMETASTATIC ACTION OF CYCLOPHOSPHANE | 2016 |
|
RU2657602C1 |
| AGENT INCREASING ANTI-METASTATIC ACTIVITY OF CYCLOPHOSPHAN | 2016 |
|
RU2613189C1 |
| AGENT BASED ON POLYSACCHARIDES FROM CALAMUS ROOT ENHANCING OF ANTI-TUMOR AND ANTI-METASTASIS ACTIVITY OF CYTOSTATIC PREPARATIONS | 2005 |
|
RU2308285C2 |
| ANTIMETASTATIC DRUG | 1993 |
|
RU2023446C1 |
| AGENTS IMPROVING ANTICANCER AND ANTIMETASTATIC ACTIVITY OF CYTOSTATICS | 2011 |
|
RU2471496C1 |
| METHOD FOR CREATING BIOLOGICAL MODEL OF MODERATE GROWTH INHIBITION OF TUMOUR AND METASTASES IN LEWIS LUNG CARCINOMA WITH PROLONGED CYCLOPHOSPHANINE-INDUCED LEUKOPENIA IN MICE | 2012 |
|
RU2488173C1 |
| METHOD OF COMBINED LIVER CANCER PC-1 THERAPY IN EXPERIMENT | 2020 |
|
RU2734143C1 |
| MEANS FOR CORRECTION OF VIOLATIONS IN HEMOGENESIS ERYTHROID LINEAGE CAUSED BY CYSTOSTATIC IMPACT | 2016 |
|
RU2634572C1 |
| METHOD FOR ENHANCING OF CYCLOPHOSPHAN ANTITUMOR AND ANTIMETASTATIC ACTIVITY IN EXPERIMENT | 2004 |
|
RU2270682C2 |
